Feb 13, 2024 / 05:40PM GMT
Jay Olson - Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst
Hello everyone and welcome to Oppenheimer's 34th Annual Healthcare Conference. I'm Jay Olson, 1 of the biotech analysts at Oppenheimer, and I want to thank you all for joining us here today. It's my pleasure to welcome Exelixis to our conference, and it's an honor to introduce Varant Shirvanian from IR and Andrew Peters, Head of Strategy. If you guys have any questions during this discussion, please feel free to submit them using the Q&A function. And with that, we'll get started. Thank you so much, Andrew and Varant, for joining us today.
Andrew Ross Peters - Exelixis, Inc. - SVP of Strategy
Yes. Thank you. Thanks for the invitation.
Questions and Answers:
Jay Olson - Oppenheimer & Co. Inc., Research Division - Executive Director & Senior AnalystIt's our pleasure. So maybe for those in our audience who aren't fully up to speed with the Exelixis story. Do you want to get us started with kind of maybe
Trustpilot
